Streetbeat News

Stock Prices

VTEX

Analysts have recently updated their ratings and price targets for Vtex (NYSE:VTEX), showing a mix of bullish and somewhat bullish sentiments. The average 12-month price target is now $10.0, reflecting a 21.21% increase from the previous target of $8.25. Analysts from JP Morgan, UBS, and Piper Sandler have adjusted their price targets and ratings, indicating a positive outlook on Vtex's financial performance, including a notable revenue growth rate of 24.52% as of March 31, 2024, and strong financial health metrics such as net margin and ROE.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 3:01 pm

AVAXUSD

Avalanche (AVAX) has seen a 3.21% decrease in price over the last 24 hours, marking a continuation of its 13% decline over the past week. The trading volume for AVAX has decreased by 2%, while its circulating supply has increased by 1.42%. Currently, AVAX's market cap ranks it 13th at $12.21 billion.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 3:01 pm

BA

Boeing reported April deliveries of 24 commercial jets, including 16 737 Max and 4 787 Dreamliner jets, with year-to-date deliveries totaling 107 aircraft. The company received 7 gross aircraft orders in April but faced 33 cancellations, primarily due to Lynx Air ceasing operations, leading to 100 net orders after cancellations and conversions for the year. The total gross orders for the year stand at 138.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 3:01 pm

FCX

Analysts have mixed views on Freeport-McMoRan (FCX), with recent ratings showing a shift towards a more neutral stance. The average 12-month price target has been raised to $54.00, indicating a 13.68% increase from the previous target. Analyst actions, including both upgrades and downgrades, reflect dynamic market conditions and company performance. Freeport-McMoRan's financials show strong revenue growth but challenges in net margin and asset utilization.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 3:01 pm

V

Visa Inc. (NYSE:V) is analyzed for its financial standing in the Financial Services industry, comparing key metrics like P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth against competitors. Visa's lower P/E ratio suggests potential undervaluation, while its high P/B and P/S ratios indicate strong market sentiment. The company's ROE, EBITDA, and gross profit are significantly above the industry average, demonstrating high profitability and operational efficiency. However, Visa's revenue growth is below the industry average, which could be a concern for future performance.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 3:00 pm

UNH

The article compares UnitedHealth Group (UNH) with its competitors in the Health Care Providers & Services industry, analyzing financial metrics like P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth. UnitedHealth shows a mix of strengths and weaknesses, with a low P/E ratio indicating potential undervaluation, a high P/B ratio suggesting a premium on its assets, and a low P/S ratio hinting at undervaluation based on sales. However, its low ROE and revenue growth compared to the industry average raise concerns about profitability and sales performance.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 3:00 pm

NKLA

Nikola Corporation's (NASDAQ:NKLA) stock is trading higher due to a rally in heavily-shorted stocks by retail investors and speculation about increased tariffs on Chinese electric vehicle imports by the Biden administration. The stock's rise is also attributed to a high short interest of 36.87% and an RSI indicating oversold conditions. Year to date, NKLA shares have lost 15.45%, outperforming its historical average annual return of -64.33%.

Portfolio Pulse from Erica Kollmann

May 14, 2024 | 3:00 pm

AVGO

The article provides a detailed comparison of Broadcom (NASDAQ:AVGO) against its competitors in the Semiconductors & Semiconductor Equipment industry, focusing on financial metrics like P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth. Broadcom is highlighted for its potential undervaluation based on P/E and P/B ratios, mixed performance in profitability and operational efficiency, and strong revenue growth.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 3:00 pm

SNPS

Over the past 5 years, Synopsys (NASDAQ:SNPS) has significantly outperformed the market, with an annualized return of 24.11% and an average annual return of 37.01%, growing a $1000 investment to $4,574.96. The company now boasts a market capitalization of $84.72 billion.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 3:00 pm

MOH

Molina Healthcare (NYSE:MOH) has delivered an average annual return of 21.82% over the past 5 years, outperforming the market by 8.91%. A $100 investment in MOH 5 years ago would now be worth $268.44. The company currently has a market capitalization of $20.64 billion.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 3:00 pm